首页 > 最新文献

BMC Complementary Medicine and Therapies最新文献

英文 中文
Rosa × damascena Herrm. From Azaran region, Kashan: rich in saturated and unsaturated fatty acids with inhibitory effect against Proteus mirabilis. Rosa × damascena Herrm.产自卡尚的阿扎兰地区:富含饱和脂肪酸和不饱和脂肪酸,对变形杆菌有抑制作用。
IF 3.3 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-09 DOI: 10.1186/s12906-024-04562-7
Mansureh Ghavam

Background: One of the most widely used medicinal plants in Iranian traditional medicine, Rosa × damascena Herrm. (mohammadi flower) that the people of Kashan use as a sedative and to treat nervous diseases and constipation. In this research, the yield, chemical composition and antimicrobial activity of the essential oil of this plant were evaluated for the first time from Azaran region, Kashan.

Methods: The essential oil was extracted by means of hydrodistillation (Clevenger), and its chemical compounds were identified and determined by GC/MS. The antimicrobial activity of the essential oil was determined by the diffusion method in agar, the minimum growth inhibitory concentration (MIC) and the minimum concentration capable of killing bacterial/fungal microorganisms (MBC/MFC).

Results: The results showed that the yield of essential oil was 0.1586 ± 0.0331% (w/w). Based on the results of the chemical composition analysis of R. x damascena essential oil, 19 different compounds (98.96%) were identified. The dominant and main components of the essential oil were oleic acid (48.08%), palmitic acid (15.44%), stearic acid (10.17%), citronellol (7.37%) and nonadecane (3.70%). Based on the results of diffusion in agar, the highest zone of inhibition against Candida albicans (ATCC 10231) was ~ 9.5 mm. The strongest inhibitory activity of R. x damascena essential oil against Gram-negative Proteus mirabilis (ATCC 43071) was with the diameter of the inhibition zone (~ 9 mm), which was equal to the strength of rifampin (~ 9 mm).

Conclusion: Therefore, this essential oil is a promising natural option rich in fatty acids, which can be a potential for the production of natural antimicrobials against infectious diseases, especially urinary tract infections.

背景:大马士革蔷薇是伊朗传统医学中使用最广泛的药用植物之一,卡尚人将其用作镇静剂,治疗神经疾病和便秘。本研究首次评估了卡尚阿扎兰地区这种植物精油的产量、化学成分和抗菌活性:方法:采用水蒸馏法(克莱文格尔)萃取精油,并通过气相色谱/质谱对其化学成分进行鉴定和测定。通过琼脂扩散法、最低生长抑制浓度(MIC)和杀死细菌/真菌微生物的最低浓度(MBC/MFC)测定了精油的抗菌活性:结果表明,精油的产量为 0.1586 ± 0.0331%(重量比)。根据大马士革香精油的化学成分分析结果,确定了 19 种不同的化合物(98.96%)。精油的主要成分为油酸(48.08%)、棕榈酸(15.44%)、硬脂酸(10.17%)、香茅醇(7.37%)和壬烷(3.70%)。根据在琼脂中的扩散结果,对白色念珠菌(ATCC 10231)的最大抑制区约为 9.5 毫米。大马士革蔷薇精油对革兰氏阴性变形杆菌(ATCC 43071)的抑制活性最强,抑制区直径(约 9 毫米)与利福平(约 9 毫米)相当:因此,这种精油是一种富含脂肪酸的天然选择,具有生产天然抗菌剂的潜力,可用于防治传染病,尤其是尿路感染。
{"title":"Rosa × damascena Herrm. From Azaran region, Kashan: rich in saturated and unsaturated fatty acids with inhibitory effect against Proteus mirabilis.","authors":"Mansureh Ghavam","doi":"10.1186/s12906-024-04562-7","DOIUrl":"10.1186/s12906-024-04562-7","url":null,"abstract":"<p><strong>Background: </strong>One of the most widely used medicinal plants in Iranian traditional medicine, Rosa × damascena Herrm. (mohammadi flower) that the people of Kashan use as a sedative and to treat nervous diseases and constipation. In this research, the yield, chemical composition and antimicrobial activity of the essential oil of this plant were evaluated for the first time from Azaran region, Kashan.</p><p><strong>Methods: </strong>The essential oil was extracted by means of hydrodistillation (Clevenger), and its chemical compounds were identified and determined by GC/MS. The antimicrobial activity of the essential oil was determined by the diffusion method in agar, the minimum growth inhibitory concentration (MIC) and the minimum concentration capable of killing bacterial/fungal microorganisms (MBC/MFC).</p><p><strong>Results: </strong>The results showed that the yield of essential oil was 0.1586 ± 0.0331% (w/w). Based on the results of the chemical composition analysis of R. x damascena essential oil, 19 different compounds (98.96%) were identified. The dominant and main components of the essential oil were oleic acid (48.08%), palmitic acid (15.44%), stearic acid (10.17%), citronellol (7.37%) and nonadecane (3.70%). Based on the results of diffusion in agar, the highest zone of inhibition against Candida albicans (ATCC 10231) was ~ 9.5 mm. The strongest inhibitory activity of R. x damascena essential oil against Gram-negative Proteus mirabilis (ATCC 43071) was with the diameter of the inhibition zone (~ 9 mm), which was equal to the strength of rifampin (~ 9 mm).</p><p><strong>Conclusion: </strong>Therefore, this essential oil is a promising natural option rich in fatty acids, which can be a potential for the production of natural antimicrobials against infectious diseases, especially urinary tract infections.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11234773/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141562679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of traditional eye medicine and self-treatment in Gurage Zone, Rural Ethiopia. 埃塞俄比亚农村地区 Gurage 区传统眼药和自我治疗的普及率。
IF 3.3 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-04 DOI: 10.1186/s12906-024-04565-4
Sadik Taju Sherief, Munira Sherefedin Sitotaw, Abonesh Girma

Introduction: Traditional medicines are commonly used worldwide, especially in Africa-however, there is limited information on the prevalence and types of traditional eye medicine utilization in Ethiopia. The goal of this study was to determine the prevalence, the type and nature of traditional eye medicine use and practices related to self-medication for ophthalmic diseases in a rural Ethiopian population.

Methods: A cross-sectional study was conducted in six randomly selected primary health centers in rural Gurage Zone, Southern Ethiopia. Health-seeking behavior, use of self-medication, and traditional eye medicine were assessed in the population using a semi-structured questionnaire. Descriptive statistics and multivariable logistic regression analysis were computed to determine associated factors for using self-medication and traditional eye medicine.

Result: Of the 814 participants interviewed, 487 (59.8%) reported using traditional eye medicine, mainly for combinations of symptoms of ocular redness, irritation, and eye discharge (95.5%). Besides, 604 (74.2%) participants reported self-treatment with tetracycline 1% eye ointment. Older age, females, low income, no formal education, and lack of access to media were risks for utilizing traditional eye medicine.

Conclusion: The use of traditional eye medicine and self-treatment are common in this population. Regulatory legislation, public awareness, and making eye care are vital activities required to monitor such practices.

简介:传统药物在世界范围内被普遍使用,尤其是在非洲,但有关埃塞俄比亚传统眼药的使用率和类型的信息却十分有限。本研究旨在确定埃塞俄比亚农村人口使用传统眼药的普遍程度、类型和性质,以及自我治疗眼科疾病的相关做法:在埃塞俄比亚南部 Gurage 地区农村随机选择了六个初级保健中心进行了横断面研究。采用半结构化问卷调查的方式,对居民的求医行为、自行用药和传统眼药进行了评估。研究人员计算了描述性统计和多变量逻辑回归分析,以确定使用自我药疗和传统眼药的相关因素:结果:在受访的 814 名参与者中,有 487 人(59.8%)表示曾使用传统眼药,主要用于治疗眼红、眼涩和眼屎等症状(95.5%)。此外,604 名受访者(74.2%)表示曾使用 1%四环素眼膏进行自我治疗。年龄较大、女性、低收入、未接受过正规教育以及缺乏接触媒体的机会是使用传统眼药的风险因素:结论:使用传统眼药和自我治疗在这一人群中很常见。结论:使用传统眼药和自我治疗在这一人群中很普遍。监管立法、提高公众意识和提供眼科护理是监测此类做法所需的重要活动。
{"title":"Prevalence of traditional eye medicine and self-treatment in Gurage Zone, Rural Ethiopia.","authors":"Sadik Taju Sherief, Munira Sherefedin Sitotaw, Abonesh Girma","doi":"10.1186/s12906-024-04565-4","DOIUrl":"10.1186/s12906-024-04565-4","url":null,"abstract":"<p><strong>Introduction: </strong>Traditional medicines are commonly used worldwide, especially in Africa-however, there is limited information on the prevalence and types of traditional eye medicine utilization in Ethiopia. The goal of this study was to determine the prevalence, the type and nature of traditional eye medicine use and practices related to self-medication for ophthalmic diseases in a rural Ethiopian population.</p><p><strong>Methods: </strong>A cross-sectional study was conducted in six randomly selected primary health centers in rural Gurage Zone, Southern Ethiopia. Health-seeking behavior, use of self-medication, and traditional eye medicine were assessed in the population using a semi-structured questionnaire. Descriptive statistics and multivariable logistic regression analysis were computed to determine associated factors for using self-medication and traditional eye medicine.</p><p><strong>Result: </strong>Of the 814 participants interviewed, 487 (59.8%) reported using traditional eye medicine, mainly for combinations of symptoms of ocular redness, irritation, and eye discharge (95.5%). Besides, 604 (74.2%) participants reported self-treatment with tetracycline 1% eye ointment. Older age, females, low income, no formal education, and lack of access to media were risks for utilizing traditional eye medicine.</p><p><strong>Conclusion: </strong>The use of traditional eye medicine and self-treatment are common in this population. Regulatory legislation, public awareness, and making eye care are vital activities required to monitor such practices.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11225267/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141533608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of Cuminum cyminum on the return of bowel motility after abdominal surgery: a triple-blind randomized clinical trial. 孜然对腹部手术后肠蠕动恢复的影响:一项三盲随机临床试验。
IF 3.3 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-04 DOI: 10.1186/s12906-024-04530-1
Esmaeili Abdar Amin, Elahabadi Ismail, Raeiszadeh Mahboobeh, Sadeghi Tabandeh

Background and objectives: Considering the significant prevalence of ileus after abdominal surgery and the beneficial effects of Cuminum cyminum in digestive problems, this study aimed to examine whether Cuminum cyminum has any effect on the return of bowel motility after abdominal surgery.

Materials and methods: In this triple-blind clinical trial study, 74 patients undergoing abdominal surgery were assigned to the intervention and control groups using minimization methods. The patients in the intervention group consumed 250 mg capsules containing Cuminum cyminum extract 4 h after the surgery and another dose of the drug 1 h afterward. The patients in the control group consumed a 250 mg capsule containing starch as a placebo at hours similar to those in the intervention group. The instruments used to collect the data were a demographic questionnaire and a researcher-made checklist to assess bowel habits. The data were analyzed using SPSS-22 software.

Results: The average time of gas passing in the intervention and control groups was 9.03 ± 3.41 and 11.72 ± 4.21 h, respectively. The defecation times in the intervention and control groups were 16.97 ± 5.02 and 26 ± 9.87 h, showing a significant difference between the two groups as indicated by the independent samples T-test (P > 0.001). Furthermore, abdominal pain, abdominal bloating, nausea, and vomiting were significantly less frequent in the intervention group compared to the control group as confirmed by Fisher's exact test (P > 0.001).

Conclusion: According to the results, the consumption of Cuminum cyminum after abdominal surgery helps to reduce the time of gas passing, defecation, and the return of bowel motility. However, additional studies need to address the effectiveness of Cuminum cyminum by changing the time and duration of its use.

背景和目的:考虑到腹部手术后回肠梗阻的发生率很高,以及孜然对消化问题的有益作用,本研究旨在探讨孜然对腹部手术后肠蠕动的恢复是否有影响:在这项三盲临床试验研究中,采用最小化方法将 74 名腹部手术患者分为干预组和对照组。干预组患者在手术后 4 小时服用 250 毫克含有孜然提取物的胶囊,并在手术后 1 小时服用另一剂量的药物。对照组患者服用 250 毫克含淀粉的胶囊作为安慰剂,服用时间与干预组相似。收集数据的工具包括一份人口统计学问卷和一份研究人员自制的排便习惯评估清单。数据使用 SPSS-22 软件进行分析:干预组和对照组的平均排气时间分别为(9.03±3.41)小时和(11.72±4.21)小时。干预组和对照组的排便时间分别为(16.97±5.02)小时和(26±9.87)小时,经独立样本 T 检验,两组差异显著(P>0.001)。此外,经费雪精确检验(P > 0.001)证实,干预组的腹痛、腹胀、恶心和呕吐发生率明显低于对照组:根据研究结果,腹部手术后服用孜然有助于减少排气、排便和肠蠕动恢复的时间。不过,还需要进行更多的研究,通过改变使用时间和持续时间来探讨孜然的有效性。
{"title":"The effect of Cuminum cyminum on the return of bowel motility after abdominal surgery: a triple-blind randomized clinical trial.","authors":"Esmaeili Abdar Amin, Elahabadi Ismail, Raeiszadeh Mahboobeh, Sadeghi Tabandeh","doi":"10.1186/s12906-024-04530-1","DOIUrl":"10.1186/s12906-024-04530-1","url":null,"abstract":"<p><strong>Background and objectives: </strong>Considering the significant prevalence of ileus after abdominal surgery and the beneficial effects of Cuminum cyminum in digestive problems, this study aimed to examine whether Cuminum cyminum has any effect on the return of bowel motility after abdominal surgery.</p><p><strong>Materials and methods: </strong>In this triple-blind clinical trial study, 74 patients undergoing abdominal surgery were assigned to the intervention and control groups using minimization methods. The patients in the intervention group consumed 250 mg capsules containing Cuminum cyminum extract 4 h after the surgery and another dose of the drug 1 h afterward. The patients in the control group consumed a 250 mg capsule containing starch as a placebo at hours similar to those in the intervention group. The instruments used to collect the data were a demographic questionnaire and a researcher-made checklist to assess bowel habits. The data were analyzed using SPSS-22 software.</p><p><strong>Results: </strong>The average time of gas passing in the intervention and control groups was 9.03 ± 3.41 and 11.72 ± 4.21 h, respectively. The defecation times in the intervention and control groups were 16.97 ± 5.02 and 26 ± 9.87 h, showing a significant difference between the two groups as indicated by the independent samples T-test (P > 0.001). Furthermore, abdominal pain, abdominal bloating, nausea, and vomiting were significantly less frequent in the intervention group compared to the control group as confirmed by Fisher's exact test (P > 0.001).</p><p><strong>Conclusion: </strong>According to the results, the consumption of Cuminum cyminum after abdominal surgery helps to reduce the time of gas passing, defecation, and the return of bowel motility. However, additional studies need to address the effectiveness of Cuminum cyminum by changing the time and duration of its use.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11229490/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141533609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evidence-based practice in traditional persian medicine (TPM): a stakeholder and social network analysis. 传统波斯医学(TPM)中的循证实践:利益相关者和社会网络分析。
IF 3.3 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-03 DOI: 10.1186/s12906-024-04564-5
Seyed Reza Abdipour Mehrian, Shahadat Uddin, Zahra Ghahramani, Reza Moshfeghinia, Saeed Shahabi, Aliakbar Haghdoost, Golsa Mesbahi, Mahmoud Khodadost, Mohammad Hashem Hashempur, Mojtaba Heydari, Morteza Mojahedi, Majid Nimrouzi, Mehdi Pasalar, Hossein Molavi Vardanjani, Kamran Bagheri Lankarani

Background: The utilization of complementary and alternative medicine (CAM) is experiencing a global surge, accompanied by the adoption of national CAM policies in numerous countries. Traditional Persian medicine (TPM) is highly used as CAM in Iran, and the ongoing scientific evaluation of its interventions and the implementation of evidence-based medicine (EBM) encounters various barriers. Therefore, comprehending the characteristics and interactions of stakeholders is pivotal in advancing EBM within TPM policies. In this study, we utilized both classical stakeholder analysis and social network analysis to identify key stakeholders and potential communication patterns, thereby promoting EBM in TPM policy-making.

Methods: A cross-sectional nationwide stakeholder analysis was conducted in 2023 using snowball sampling. The interviews were carried out using a customized version of the six building blocks of health. Data were collected through semi-structured interviews. Stakeholders were assessed based on five factors (power, interest, influence, position, and competency). The connections and structure of the network were analyzed using degree, betweenness, closeness centrality, and modularity index to detect clusters of smaller networks.

Results: Among twenty-three identified stakeholders, the Ministry of Health and Medical Education (MOHME) and the Public were the most powerful and influential. The Iranian Academy of Medical Sciences was the most competent stakeholder. Social network analysis revealed a low density of connections among stakeholders. Pharmaceutical companies were identified as key connectors in the network, while the Public, supreme governmental bodies, and guilds acted as gatekeepers or brokers. The MOHME and Maraji were found to be high-ranking stakeholders based on four different centrality measures.

Conclusion: This study identifies powerful stakeholders in the network and emphasizes the need to engage uninterested yet significant stakeholders. Recommendations include improving competence through education, strengthening international relations, and fostering stronger relationships. Engaging key connectors and gatekeepers is essential for bridging gaps in the network.

背景:补充和替代医学(CAM)的使用在全球范围内激增,许多国家也采取了国家 CAM 政策。在伊朗,波斯传统医学(TPM)作为 CAM 的使用率很高,对其干预措施的持续科学评估和循证医学(EBM)的实施遇到了各种障碍。因此,了解利益相关者的特点和相互作用对于在 TPM 政策中推进 EBM 至关重要。在本研究中,我们利用经典的利益相关者分析和社会网络分析来确定主要利益相关者和潜在的沟通模式,从而促进在预防性医疗政策制定中的 EBM:方法:2023 年,我们采用滚雪球抽样法对全国范围内的利益相关者进行了横向分析。访谈采用了定制版的 "健康六大要素"。通过半结构化访谈收集数据。根据五个因素(权力、兴趣、影响力、地位和能力)对利益相关者进行了评估。使用度数、间隔度、接近度中心性和模块化指数对网络的连接和结构进行分析,以发现较小的网络集群:在确定的 23 个利益相关者中,卫生与医学教育部(MOHME)和公众最有权力和影响力。伊朗医学科学院是最有能力的利益相关者。社会网络分析显示,利益相关者之间的联系密度较低。制药公司被认为是网络中的关键连接者,而公众、最高政府机构和行会则充当看门人或中间人。根据四种不同的中心度量,卫生部和马拉吉被认为是高级利益相关者:本研究确定了网络中强大的利益相关者,并强调了让不感兴趣但重要的利益相关者参与进来的必要性。建议包括通过教育提高能力、加强国际关系和促进更牢固的关系。让关键的连接者和守门人参与进来对于弥合网络中的差距至关重要。
{"title":"Evidence-based practice in traditional persian medicine (TPM): a stakeholder and social network analysis.","authors":"Seyed Reza Abdipour Mehrian, Shahadat Uddin, Zahra Ghahramani, Reza Moshfeghinia, Saeed Shahabi, Aliakbar Haghdoost, Golsa Mesbahi, Mahmoud Khodadost, Mohammad Hashem Hashempur, Mojtaba Heydari, Morteza Mojahedi, Majid Nimrouzi, Mehdi Pasalar, Hossein Molavi Vardanjani, Kamran Bagheri Lankarani","doi":"10.1186/s12906-024-04564-5","DOIUrl":"10.1186/s12906-024-04564-5","url":null,"abstract":"<p><strong>Background: </strong>The utilization of complementary and alternative medicine (CAM) is experiencing a global surge, accompanied by the adoption of national CAM policies in numerous countries. Traditional Persian medicine (TPM) is highly used as CAM in Iran, and the ongoing scientific evaluation of its interventions and the implementation of evidence-based medicine (EBM) encounters various barriers. Therefore, comprehending the characteristics and interactions of stakeholders is pivotal in advancing EBM within TPM policies. In this study, we utilized both classical stakeholder analysis and social network analysis to identify key stakeholders and potential communication patterns, thereby promoting EBM in TPM policy-making.</p><p><strong>Methods: </strong>A cross-sectional nationwide stakeholder analysis was conducted in 2023 using snowball sampling. The interviews were carried out using a customized version of the six building blocks of health. Data were collected through semi-structured interviews. Stakeholders were assessed based on five factors (power, interest, influence, position, and competency). The connections and structure of the network were analyzed using degree, betweenness, closeness centrality, and modularity index to detect clusters of smaller networks.</p><p><strong>Results: </strong>Among twenty-three identified stakeholders, the Ministry of Health and Medical Education (MOHME) and the Public were the most powerful and influential. The Iranian Academy of Medical Sciences was the most competent stakeholder. Social network analysis revealed a low density of connections among stakeholders. Pharmaceutical companies were identified as key connectors in the network, while the Public, supreme governmental bodies, and guilds acted as gatekeepers or brokers. The MOHME and Maraji were found to be high-ranking stakeholders based on four different centrality measures.</p><p><strong>Conclusion: </strong>This study identifies powerful stakeholders in the network and emphasizes the need to engage uninterested yet significant stakeholders. Recommendations include improving competence through education, strengthening international relations, and fostering stronger relationships. Engaging key connectors and gatekeepers is essential for bridging gaps in the network.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11223371/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141497121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safe use elements of finished herbal products: insights from consumers and practitioners in Malaysia. 草药成品的安全使用要素:马来西亚消费者和从业人员的见解。
IF 3.3 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-03 DOI: 10.1186/s12906-024-04546-7
Nur Syamila Mohd Roziman, Wardah Mustafa Din, Zurina Mahadi, Farida Islahudin, Mazlina Md Said

Background: The use of finished herbal products (FHPs) among Malaysians today is expanding rapidly leading to a huge market of FHPs in the country. However, the mass production of FHPs in today's market is alarming due to safety-use issues that could lead to serious adverse effects. Nevertheless, demands are still high for FHPs as most consumers perceived it as safe to consume as it is made from natural substances as the active ingredients. This study aims to explore the safe use elements of FHPs identified by two stakeholders: consumers and practitioners in Malaysia and further compare these elements with the current regulations.

Methods: As an exploratory study, its approach is to investigate at an in-depth level of understanding of safe use elements from the involved stakeholders: consumers and practitioners. We had a total of 4 focus group discussion sessions (1 FGD session with consumer and 3 FGD sessions with practitioners) as a method of collecting data from the participants. The FGDs were conducted in local native Malaysian and then being translated by researchers without changing their meanings. Thematic analysis was done which involves methodically reading through the verbatim transcripts and consequently segmenting and coding the text into categories that highlight what the participants have discussed.

Results: From the result, we found that both practitioners and consumers agreed a safe FHP must be in compliance with the guidelines from the Ministry of Health Malaysia (MOH). There are other safe use elements highlighted including halal certification, trusted over-the-counter outlets, and published reports on the safety, efficacy, and quality.

Conclusions: In conclusion, both practitioners and consumers agreed that the most important safe-use element is compliance with MOH guidelines, but the depth of discussion regarding the safety elements among these stakeholders holds a very huge gap. Thus, initiatives must be planned to increase the knowledge and understanding about the MOH guidelines towards achieving a sustainable ecosystem in the safe use of FHPs.

背景:如今,马来西亚人对草药成品(FHPs)的使用正在迅速扩大,从而导致该国出现了一个巨大的 FHPs 市场。然而,由于可能导致严重不良影响的安全使用问题,当今市场上大量生产的 FHPs 令人担忧。尽管如此,消费者对 FHPs 的需求仍然很高,因为大多数消费者认为 FHPs 由天然物质作为活性成分制成,食用安全。本研究旨在探讨马来西亚消费者和从业人员这两个利益相关者所确定的 FHPs 安全使用要素,并进一步将这些要素与现行法规进行比较:作为一项探索性研究,其方法是深入调查相关利益方(消费者和从业人员)对安全使用要素的理解。我们共进行了 4 次焦点小组讨论(1 次消费者焦点小组讨论和 3 次从业人员焦点小组讨论),以此作为收集参与者数据的方法。FGD 以马来西亚当地语言进行,然后由研究人员在不改变其含义的情况下进行翻译。专题分析包括有条不紊地阅读逐字记录稿,然后对文本进行分段和编码,以突出参与者所讨论的内容:结果:我们发现,从业人员和消费者都认为,安全的 FHP 必须符合马来西亚卫生部(MOH)的指导方针。我们还强调了其他安全使用要素,包括清真认证、值得信赖的非处方销售点以及有关安全性、有效性和质量的公开报告:总之,从业人员和消费者都认为,最重要的安全使用要素是遵守卫生部的指导方针,但这些利益相关者对安全要素的讨论深度还存在很大差距。因此,必须计划采取各种措施,提高人们对卫生部指导方针的认识和理解,以实现安全使用快速保健品的可持续生态系统。
{"title":"Safe use elements of finished herbal products: insights from consumers and practitioners in Malaysia.","authors":"Nur Syamila Mohd Roziman, Wardah Mustafa Din, Zurina Mahadi, Farida Islahudin, Mazlina Md Said","doi":"10.1186/s12906-024-04546-7","DOIUrl":"10.1186/s12906-024-04546-7","url":null,"abstract":"<p><strong>Background: </strong>The use of finished herbal products (FHPs) among Malaysians today is expanding rapidly leading to a huge market of FHPs in the country. However, the mass production of FHPs in today's market is alarming due to safety-use issues that could lead to serious adverse effects. Nevertheless, demands are still high for FHPs as most consumers perceived it as safe to consume as it is made from natural substances as the active ingredients. This study aims to explore the safe use elements of FHPs identified by two stakeholders: consumers and practitioners in Malaysia and further compare these elements with the current regulations.</p><p><strong>Methods: </strong>As an exploratory study, its approach is to investigate at an in-depth level of understanding of safe use elements from the involved stakeholders: consumers and practitioners. We had a total of 4 focus group discussion sessions (1 FGD session with consumer and 3 FGD sessions with practitioners) as a method of collecting data from the participants. The FGDs were conducted in local native Malaysian and then being translated by researchers without changing their meanings. Thematic analysis was done which involves methodically reading through the verbatim transcripts and consequently segmenting and coding the text into categories that highlight what the participants have discussed.</p><p><strong>Results: </strong>From the result, we found that both practitioners and consumers agreed a safe FHP must be in compliance with the guidelines from the Ministry of Health Malaysia (MOH). There are other safe use elements highlighted including halal certification, trusted over-the-counter outlets, and published reports on the safety, efficacy, and quality.</p><p><strong>Conclusions: </strong>In conclusion, both practitioners and consumers agreed that the most important safe-use element is compliance with MOH guidelines, but the depth of discussion regarding the safety elements among these stakeholders holds a very huge gap. Thus, initiatives must be planned to increase the knowledge and understanding about the MOH guidelines towards achieving a sustainable ecosystem in the safe use of FHPs.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11223321/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141497122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimization of the extraction process for Shenshou Taiyi powder based on Box-Behnken experimental design, standard relation, and FAHP-CRITIC methods. 基于 Box-Behnken 实验设计、标准关系和 FAHP-CRITIC 方法的神寿太乙粉提取工艺优化。
IF 3.3 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-02 DOI: 10.1186/s12906-024-04554-7
Mengcheng Jiang, Zhidong Qiu, Yuanyuan Diao, Yuwen Shi, Weipeng Liu, Na Li, Ailing Jia

Background: Ancient classic prescription play a crucial role in the preservation and advancement of traditional Chinese medicine (TCM) theories. They represent a significant milestone in the ongoing development and transmission of TCM knowledge and practices and are considered one of the breakthroughs in the development of TCM inheritance. In the process of developing ancient classic prescriptions, many problems may still arise in ensuring quality consistency between traditional methods and modern production processes, among which the extraction process poses major challenges. This paper introduces a practical approach extracting an ancient classic prescription using a modern extraction process. The technique is demonstrated through the study of the extraction process of Shenshou Taiyi powder (STP).

Methods: This study focuses on optimising the STP extraction process to ensure consistency in the quality of the product obtained through ancient and modern processes using the standard relation and fuzzy analytic hierarchical process (FAHP) and criteria importance through intercriteria correlation (CRITIC) method integrated weights combined with the Box-Behnken response surface test. Using the contents of rosmarinic acid, isoimperatorin, puerarin, as well as the extract yield and fingerprint similarity as evaluation indexes of STP, the Box-Behnken response surface method was employed to examine the varying extraction parameters, including water addition ratio, extraction duration, and number of extractions. The weighted coefficients for each parameter were calculated by combining the benchmark correlation and FAHP-CRITIC method, deriving a comprehensive score.

Results: The optimal extraction process for STP consisted of a two extractions, each using at a tenfold quantity of water, performed for one hour. Process verification across three separate batches yielded a comprehensive score of 94.7, with a relative standard deviation of 0.76%.

Conclusions: The application of the Box-Behnken response surface method combined with standard relation and FAHP-CRITIC approach proved to be stable and feasible for optimising the extraction process of STP.

背景:古代经典处方在保存和发扬传统中医理论方面发挥着至关重要的作用。它们是中医药知识和实践不断发展和传承的重要里程碑,被认为是中医药传承发展的突破口之一。在开发古代经典处方的过程中,为确保传统方法与现代生产工艺之间的质量一致性,仍可能出现许多问题,其中提取工艺就构成了重大挑战。本文介绍了一种利用现代提取工艺提取古代经典处方的实用方法。通过对神寿太乙散(STP)提取工艺的研究,展示了这一技术:本研究的重点是利用标准关系和模糊分析层次过程(FAHP)以及标准间相关性标准重要性(CRITIC)方法的综合权重,结合方框-贝肯响应面测试,优化神寿太一粉的提取工艺,以确保通过古代和现代工艺获得的产品质量的一致性。以迷迭香酸、异迷迭香苷、葛根素的含量以及提取率和指纹图谱相似度作为 STP 的评价指标,采用盒-贝肯响应面法考察了不同的提取参数,包括加水量、提取时间和提取次数。结合基准相关法和 FAHP-CRITIC 法计算出各参数的加权系数,得出综合得分:STP 的最佳萃取工艺包括两次萃取,每次萃取使用十倍量的水,萃取时间为一小时。通过对三个独立批次的工艺验证,得出的综合评分为 94.7 分,相对标准偏差为 0.76%:方框-贝肯响应面法结合标准关系和 FAHP-CRITIC 方法的应用被证明在优化 STP 的提取工艺方面是稳定可行的。
{"title":"Optimization of the extraction process for Shenshou Taiyi powder based on Box-Behnken experimental design, standard relation, and FAHP-CRITIC methods.","authors":"Mengcheng Jiang, Zhidong Qiu, Yuanyuan Diao, Yuwen Shi, Weipeng Liu, Na Li, Ailing Jia","doi":"10.1186/s12906-024-04554-7","DOIUrl":"10.1186/s12906-024-04554-7","url":null,"abstract":"<p><strong>Background: </strong>Ancient classic prescription play a crucial role in the preservation and advancement of traditional Chinese medicine (TCM) theories. They represent a significant milestone in the ongoing development and transmission of TCM knowledge and practices and are considered one of the breakthroughs in the development of TCM inheritance. In the process of developing ancient classic prescriptions, many problems may still arise in ensuring quality consistency between traditional methods and modern production processes, among which the extraction process poses major challenges. This paper introduces a practical approach extracting an ancient classic prescription using a modern extraction process. The technique is demonstrated through the study of the extraction process of Shenshou Taiyi powder (STP).</p><p><strong>Methods: </strong>This study focuses on optimising the STP extraction process to ensure consistency in the quality of the product obtained through ancient and modern processes using the standard relation and fuzzy analytic hierarchical process (FAHP) and criteria importance through intercriteria correlation (CRITIC) method integrated weights combined with the Box-Behnken response surface test. Using the contents of rosmarinic acid, isoimperatorin, puerarin, as well as the extract yield and fingerprint similarity as evaluation indexes of STP, the Box-Behnken response surface method was employed to examine the varying extraction parameters, including water addition ratio, extraction duration, and number of extractions. The weighted coefficients for each parameter were calculated by combining the benchmark correlation and FAHP-CRITIC method, deriving a comprehensive score.</p><p><strong>Results: </strong>The optimal extraction process for STP consisted of a two extractions, each using at a tenfold quantity of water, performed for one hour. Process verification across three separate batches yielded a comprehensive score of 94.7, with a relative standard deviation of 0.76%.</p><p><strong>Conclusions: </strong>The application of the Box-Behnken response surface method combined with standard relation and FAHP-CRITIC approach proved to be stable and feasible for optimising the extraction process of STP.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11221082/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141490871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protocol for a pragmatic trial of Cannabidiol (CBD) to improve chronic pain symptoms among United States Veterans. 大麻二酚(CBD)改善美国退伍军人慢性疼痛症状的实用试验方案。
IF 3.3 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-06-29 DOI: 10.1186/s12906-024-04558-3
Rachel S Bergmans, Riley Wegryn-Jones, Catherine Klida, Vivian Kurtz, Laura Thomas, David A Williams, Daniel J Clauw, Kelley M Kidwell, Amy S B Bohnert, Kevin F Boehnke

Background: Chronic pain affects over 100 million Americans, with a disproportionately high number being Veterans. Chronic pain is often difficult to treat and responds variably to medications, with many providing minimal relief or having adverse side effects that preclude use. Cannabidiol (CBD) has emerged as a potential treatment for chronic pain, yet research in this area remains limited, with few studies examining CBD's analgesic potential. Because Veterans have a high need for improved pain care, we designed a clinical trial to investigate CBD's effectiveness in managing chronic pain symptoms among Veterans. We aim to determine whether CBD oral solution compared to placebo study medication is associated with greater improvement in the Patient Global Impression of Change (PGIC).

Methods: We designed a randomized, double-blind, placebo-controlled, pragmatic clinical trial with 468 participants. Participants will be randomly assigned in a 1:1 ratio to receive either placebo or a CBD oral solution over a 4-week period. The trial is remote via a smartphone app and by shipping study materials, including study medication, to participants. We will compare the difference in PGIC between the CBD and placebo group after four weeks and impacts on secondary outcomes (e.g., pain severity, pain interference, anxiety, suicide ideation, and sleep disturbance).

Discussion: Once complete, this trial will be among the largest to date investigating the efficacy of CBD for chronic pain. Findings from this clinical trial will contribute to a greater knowledge of CBD's analgesic potential and guide further research. Given the relative availability of CBD, our findings will help elucidate the potential of an accessible option for helping to manage chronic pain among Veterans.

Trial registration: This protocol is registered at clinicaltrials.gov under study number NCT06213233.

背景:超过 1 亿美国人受到慢性疼痛的影响,其中退伍军人的数量尤其多。慢性疼痛通常很难治疗,对药物的反应也不尽相同,许多药物只能缓解极小的疼痛,或有不良副作用,无法使用。大麻二酚(CBD)已成为治疗慢性疼痛的一种潜在方法,但这方面的研究仍然有限,很少有研究探讨 CBD 的镇痛潜力。由于退伍军人对改善疼痛护理的需求很大,因此我们设计了一项临床试验,以调查 CBD 对退伍军人慢性疼痛症状的治疗效果。我们的目标是确定与安慰剂研究药物相比,CBD 口服溶液是否与患者全球变化印象(PGIC)的更大改善相关:我们设计了一项随机、双盲、安慰剂对照、务实的临床试验,共有 468 人参加。参与者将按 1:1 的比例随机分配,在为期 4 周的时间内接受安慰剂或 CBD 口服液的治疗。该试验通过智能手机应用程序和向参与者寄送研究材料(包括研究药物)的方式进行。我们将比较四周后 CBD 组和安慰剂组在 PGIC 方面的差异,以及对次要结果(如疼痛严重程度、疼痛干扰、焦虑、自杀意念和睡眠障碍)的影响:这项试验一旦完成,将成为迄今为止研究 CBD 对慢性疼痛疗效的最大规模试验之一。这项临床试验的结果将有助于进一步了解 CBD 的镇痛潜力,并为进一步的研究提供指导。考虑到 CBD 的相对可得性,我们的研究结果将有助于阐明这种可获得的选择在帮助退伍军人控制慢性疼痛方面的潜力:本方案已在 clinicaltrials.gov 注册,研究编号为 NCT06213233。
{"title":"Protocol for a pragmatic trial of Cannabidiol (CBD) to improve chronic pain symptoms among United States Veterans.","authors":"Rachel S Bergmans, Riley Wegryn-Jones, Catherine Klida, Vivian Kurtz, Laura Thomas, David A Williams, Daniel J Clauw, Kelley M Kidwell, Amy S B Bohnert, Kevin F Boehnke","doi":"10.1186/s12906-024-04558-3","DOIUrl":"10.1186/s12906-024-04558-3","url":null,"abstract":"<p><strong>Background: </strong>Chronic pain affects over 100 million Americans, with a disproportionately high number being Veterans. Chronic pain is often difficult to treat and responds variably to medications, with many providing minimal relief or having adverse side effects that preclude use. Cannabidiol (CBD) has emerged as a potential treatment for chronic pain, yet research in this area remains limited, with few studies examining CBD's analgesic potential. Because Veterans have a high need for improved pain care, we designed a clinical trial to investigate CBD's effectiveness in managing chronic pain symptoms among Veterans. We aim to determine whether CBD oral solution compared to placebo study medication is associated with greater improvement in the Patient Global Impression of Change (PGIC).</p><p><strong>Methods: </strong>We designed a randomized, double-blind, placebo-controlled, pragmatic clinical trial with 468 participants. Participants will be randomly assigned in a 1:1 ratio to receive either placebo or a CBD oral solution over a 4-week period. The trial is remote via a smartphone app and by shipping study materials, including study medication, to participants. We will compare the difference in PGIC between the CBD and placebo group after four weeks and impacts on secondary outcomes (e.g., pain severity, pain interference, anxiety, suicide ideation, and sleep disturbance).</p><p><strong>Discussion: </strong>Once complete, this trial will be among the largest to date investigating the efficacy of CBD for chronic pain. Findings from this clinical trial will contribute to a greater knowledge of CBD's analgesic potential and guide further research. Given the relative availability of CBD, our findings will help elucidate the potential of an accessible option for helping to manage chronic pain among Veterans.</p><p><strong>Trial registration: </strong>This protocol is registered at clinicaltrials.gov under study number NCT06213233.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11218053/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141475928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pityriasis Rosea-Like Eruption following anti-fatigue traditional herbs: Aconitum carmichaelii Debx and Panax Ginseng suspected. 服用抗疲劳传统草药后出现玫瑰糠疹样发作:疑似 Aconitum carmichaelii Debx 和 Panax Ginseng。
IF 3.3 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-06-29 DOI: 10.1186/s12906-024-04556-5
Xueyan Zeng, Xin Zhou, Aiping Zhang, Yanqin Zhu, Bin Lu, Feiqin Zhu, Mengqi Wu, Riyang Lin

Traditional herbs have a history of clinical use in anti-fatigue. However, several adverse effects of herbs have been identified. Pityriasis rosea-like eruption (PR-LE) is a rare cutaneous complication of herbs. To the best of our knowledge, there have been few reports of PR-LE following herbs. Here, we described a case of PR-LE that developed 6 days after taking anti-fatigue herbs. After the 17 days of stopping Aconitum carmichaelii Debx and Panax Ginseng, it notably faded. So, when anti-fatigue herbs being authorized for fatigue use, monitoring for potential adverse effects is necessary.

传统草药在抗疲劳方面已有临床应用的历史。然而,中草药也有一些不良反应。玫瑰糠疹样糜烂(PR-LE)是一种罕见的中草药皮肤并发症。据我们所知,有关服用中草药后出现玫瑰糠疹样糜烂的报道很少。在这里,我们描述了一例在服用抗疲劳草药 6 天后出现的 PR-LE 病例。在停用 Aconitum carmichaelii Debx 和人参 17 天后,PR-LE 明显消退。因此,当抗疲劳草药被授权用于抗疲劳时,有必要监测潜在的不良反应。
{"title":"Pityriasis Rosea-Like Eruption following anti-fatigue traditional herbs: Aconitum carmichaelii Debx and Panax Ginseng suspected.","authors":"Xueyan Zeng, Xin Zhou, Aiping Zhang, Yanqin Zhu, Bin Lu, Feiqin Zhu, Mengqi Wu, Riyang Lin","doi":"10.1186/s12906-024-04556-5","DOIUrl":"10.1186/s12906-024-04556-5","url":null,"abstract":"<p><p>Traditional herbs have a history of clinical use in anti-fatigue. However, several adverse effects of herbs have been identified. Pityriasis rosea-like eruption (PR-LE) is a rare cutaneous complication of herbs. To the best of our knowledge, there have been few reports of PR-LE following herbs. Here, we described a case of PR-LE that developed 6 days after taking anti-fatigue herbs. After the 17 days of stopping Aconitum carmichaelii Debx and Panax Ginseng, it notably faded. So, when anti-fatigue herbs being authorized for fatigue use, monitoring for potential adverse effects is necessary.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11218121/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141475912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What is the state of the art on traditional medicine interventions for zoonotic diseases in the Indian subcontinent? A scoping review of the peer-reviewed evidence base. 印度次大陆人畜共患病的传统医学干预技术现状如何?同行评审证据基础的范围界定审查。
IF 3.3 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-06-29 DOI: 10.1186/s12906-024-04553-8
Festus A Asaaga, Emmanuel S Tomude, Mujeeb Rahman, Irfan Shakeer, Nitya S Ghotge, Sarah J Burthe, Stefanie M Schäfer, Abi T Vanak, Bethan V Purse, Subhash L Hoti

Background: Traditional medicine (TM) interventions are plausible therapeutic alternatives to conventional medical interventions against emerging and endemic zoonotic diseases, particularly in low-and middle-income countries that may lack resources and infrastructure. Despite the growing popularity in the usage of TM interventions, their clinical safety and effectiveness are still contested within conventional healthcare in many countries.

Methods: We conducted a scoping review of the peer-reviewed literature that synthesises and maps the evidence on TM interventions for the treatment and prevention of zoonoses on the Indian subcontinent. The region, a global hotspot of biodiversity and emerging infections, is characterised by high prevalence of TM use. Based on the scientific literature (mostly case study research, n=l06 studies), our review (1) maps the scope of the literature, (2) synthesises the evidence on the application of TM interventions for zoonoses, and (3) critically reflects on the state of TM and identifies areas for future research focus.

Results: The evidence synthesis confirmed widespread usage of TM interventions for zoonoses on the subcontinent, with the majority of research reported from India (n=99 studies, 93.4%), followed by Pakistan (n=3 studies, 2.8%), Bangladesh (n=2 studies, 1.9%), and Sri Lanka (n=1, 0.9%). Most of the reviewed studies reported on ethno-medicinal uses of plant species, primarily for treating dengue (n=20 studies), tuberculosis (n=18 studies), Escherichia coli infection (n=16 studies), lymphatic filariasis and cholera (n=9 apiece). However, the evidence on the safety and effectiveness of these reported TM interventions is limited, indicating that these data are rarely collected and/or shared within the peer-reviewed literature.

Conclusion: This review thus highlights that, whilst TMs are already being used and could offer more widely accessible interventions against emerging and endemic zoonoses and ectoparasites, there is an urgent need for rigorous clinical testing and validation of the safety and effectiveness of these interventions.

背景:传统医学(TM)干预措施是传统医学干预措施的合理替代疗法,可用于防治新出现的地方性人畜共患病,尤其是在缺乏资源和基础设施的中低收入国家。尽管传统疗法干预的使用日益普及,但在许多国家的传统医疗保健中,其临床安全性和有效性仍存在争议:方法:我们对同行评审的文献进行了一次范围界定审查,对印度次大陆用于治疗和预防人畜共患病的传统疗法干预措施的证据进行了综合和映射。该地区是全球生物多样性和新发传染病的热点地区,其特点是使用传统疗法的比例很高。我们的综述以科学文献(大多为案例研究,n=106 项研究)为基础,(1) 规划了文献范围,(2) 综合了有关应用技术疗法干预人畜共患病的证据,(3) 批判性地反思了技术疗法的现状,并确定了未来研究的重点领域:证据综述证实,在印度次大陆广泛使用技术疗法干预人畜共患病,大多数研究报告来自印度(99 项研究,占 93.4%),其次是巴基斯坦(3 项研究,占 2.8%)、孟加拉国(2 项研究,占 1.9%)和斯里兰卡(1 项研究,占 0.9%)。大多数综述研究报告了植物物种的民族药用用途,主要用于治疗登革热(20 项研究)、肺结核(18 项研究)、大肠杆菌感染(16 项研究)、淋巴丝虫病和霍乱(各 9 项研究)。然而,关于这些已报道的传统疗法干预措施的安全性和有效性的证据却很有限,这表明这些数据很少在同行评审的文献中收集和/或分享:因此,本综述强调,虽然目前已经在使用传统媒介,而且可以提供更广泛的干预措施来防治新出现和流行的人畜共患疾病和体外寄生虫,但仍迫切需要对这些干预措施的安全性和有效性进行严格的临床测试和验证。
{"title":"What is the state of the art on traditional medicine interventions for zoonotic diseases in the Indian subcontinent? A scoping review of the peer-reviewed evidence base.","authors":"Festus A Asaaga, Emmanuel S Tomude, Mujeeb Rahman, Irfan Shakeer, Nitya S Ghotge, Sarah J Burthe, Stefanie M Schäfer, Abi T Vanak, Bethan V Purse, Subhash L Hoti","doi":"10.1186/s12906-024-04553-8","DOIUrl":"10.1186/s12906-024-04553-8","url":null,"abstract":"<p><strong>Background: </strong>Traditional medicine (TM) interventions are plausible therapeutic alternatives to conventional medical interventions against emerging and endemic zoonotic diseases, particularly in low-and middle-income countries that may lack resources and infrastructure. Despite the growing popularity in the usage of TM interventions, their clinical safety and effectiveness are still contested within conventional healthcare in many countries.</p><p><strong>Methods: </strong>We conducted a scoping review of the peer-reviewed literature that synthesises and maps the evidence on TM interventions for the treatment and prevention of zoonoses on the Indian subcontinent. The region, a global hotspot of biodiversity and emerging infections, is characterised by high prevalence of TM use. Based on the scientific literature (mostly case study research, n=l06 studies), our review (1) maps the scope of the literature, (2) synthesises the evidence on the application of TM interventions for zoonoses, and (3) critically reflects on the state of TM and identifies areas for future research focus.</p><p><strong>Results: </strong>The evidence synthesis confirmed widespread usage of TM interventions for zoonoses on the subcontinent, with the majority of research reported from India (n=99 studies, 93.4%), followed by Pakistan (n=3 studies, 2.8%), Bangladesh (n=2 studies, 1.9%), and Sri Lanka (n=1, 0.9%). Most of the reviewed studies reported on ethno-medicinal uses of plant species, primarily for treating dengue (n=20 studies), tuberculosis (n=18 studies), Escherichia coli infection (n=16 studies), lymphatic filariasis and cholera (n=9 apiece). However, the evidence on the safety and effectiveness of these reported TM interventions is limited, indicating that these data are rarely collected and/or shared within the peer-reviewed literature.</p><p><strong>Conclusion: </strong>This review thus highlights that, whilst TMs are already being used and could offer more widely accessible interventions against emerging and endemic zoonoses and ectoparasites, there is an urgent need for rigorous clinical testing and validation of the safety and effectiveness of these interventions.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11218393/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141475929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ginsenoside Rg3 attenuates myocardial ischemia/reperfusion-induced ferroptosis via the keap1/Nrf2/GPX4 signaling pathway. 人参皂苷Rg3通过keap1/Nrf2/GPX4信号通路减轻心肌缺血/再灌注诱导的铁细胞减少症
IF 3.3 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-06-26 DOI: 10.1186/s12906-024-04492-4
GuoFu Zhong, Junteng Chen, Yangtao Li, Yue Han, Maosheng Wang, Qinqi Nie, Mujuan Xu, Qinghua Zhu, Xiao Chang, Ling Wang

Background: Ginsenoside Rg3 is a component of ginseng that protects against myocardial ischemia/reperfusion (MI/R) injury. Ferroptosis is a new form of cell death characterized by oxidative damage to phospholipids. The purpose of this study was to examine the role and of ginsenoside Rg3 in MI/R and the mechanism.

Methods: A mouse model of left anterior descending (LAD) ligation-induced myocardial ischemia/reperfusion (MI/R) injury and oxygen-glucose deprivation/reperfusion (OGD/R) were used as in vitro and in vivo models, respectively. Echocardiographic analysis, 2,3,5-triphenyltetrazolium chloride (TTC) staining and hematoxylin-eosin (H&E) staining were used to assess the cardioprotective effects of ginsenoside Rg3. Western blotting, biochemical analysis, small interfering RNA analysis and molecular docking were performed to examine the underlying mechanism.

Results: Ginsenoside Rg3 improved cardiac function and infarct size in mice with MI/R injury. Moreover, ginsenoside Rg3 increased the expression of the ferroptosis-related protein GPX4 and inhibited iron deposition in mice with MI/R injury. Ginsenoside Rg3 also activated the Nrf2 signaling pathway. Ginsenoside Rg3 attenuated myocardial ischemia/reperfusion-induced ferroptosis via the Nrf2 signaling pathway. Notably, ginsenoside Rg3 regulated the keap1/Nrf2 signaling pathway to attenuate OGD/R-induced ferroptosis in H9C2 cells. Taken together, ginsenoside Rg3 attenuated myocardial ischemia/reperfusion-induced ferroptosis via the keap1/Nrf2/GPX4 signaling pathway.

Conclusions: Our findings demonstrated that ginsenoside Rg3 ameliorate MI/R-induced ferroptosis via the keap1/Nrf2/GPX4 signaling pathway.

背景:人参皂苷 Rg3 是人参的一种成分,可防止心肌缺血/再灌注(MI/R)损伤。铁凋亡是一种新的细胞死亡形式,其特点是磷脂的氧化损伤。本研究旨在探讨人参皂苷 Rg3 在 MI/R 损伤中的作用和机制:方法:分别使用左前降支(LAD)结扎诱导的心肌缺血再灌注(MI/R)损伤小鼠模型和氧-葡萄糖剥夺/再灌注(OGD/R)小鼠模型作为体外和体内模型。通过超声心动图分析、2,3,5-三苯基氯化四氮唑(TTC)染色和苏木精-伊红(H&E)染色来评估人参皂苷Rg3的心脏保护作用。此外,还进行了Western印迹、生化分析、小干扰RNA分析和分子对接,以研究其潜在机制:结果:人参皂苷Rg3改善了心肌梗死/再损伤小鼠的心功能和梗死面积。此外,人参皂苷 Rg3 还能增加铁氧化相关蛋白 GPX4 的表达,抑制 MI/R 损伤小鼠的铁沉积。人参皂苷 Rg3 还能激活 Nrf2 信号通路。人参皂苷Rg3通过Nrf2信号通路减轻了心肌缺血/再灌注诱导的铁沉积。值得注意的是,人参皂苷Rg3调节了keap1/Nrf2信号通路,从而减轻了OGD/R-诱导的H9C2细胞铁突变。综上所述,人参皂苷Rg3通过keap1/Nrf2/GPX4信号通路减轻了心肌缺血/再灌注诱导的铁沉着:我们的研究结果表明,人参皂苷Rg3可通过keap1/Nrf2/GPX4信号通路改善心肌缺血/再灌注诱导的铁沉着。
{"title":"Ginsenoside Rg3 attenuates myocardial ischemia/reperfusion-induced ferroptosis via the keap1/Nrf2/GPX4 signaling pathway.","authors":"GuoFu Zhong, Junteng Chen, Yangtao Li, Yue Han, Maosheng Wang, Qinqi Nie, Mujuan Xu, Qinghua Zhu, Xiao Chang, Ling Wang","doi":"10.1186/s12906-024-04492-4","DOIUrl":"10.1186/s12906-024-04492-4","url":null,"abstract":"<p><strong>Background: </strong>Ginsenoside Rg3 is a component of ginseng that protects against myocardial ischemia/reperfusion (MI/R) injury. Ferroptosis is a new form of cell death characterized by oxidative damage to phospholipids. The purpose of this study was to examine the role and of ginsenoside Rg3 in MI/R and the mechanism.</p><p><strong>Methods: </strong>A mouse model of left anterior descending (LAD) ligation-induced myocardial ischemia/reperfusion (MI/R) injury and oxygen-glucose deprivation/reperfusion (OGD/R) were used as in vitro and in vivo models, respectively. Echocardiographic analysis, 2,3,5-triphenyltetrazolium chloride (TTC) staining and hematoxylin-eosin (H&E) staining were used to assess the cardioprotective effects of ginsenoside Rg3. Western blotting, biochemical analysis, small interfering RNA analysis and molecular docking were performed to examine the underlying mechanism.</p><p><strong>Results: </strong>Ginsenoside Rg3 improved cardiac function and infarct size in mice with MI/R injury. Moreover, ginsenoside Rg3 increased the expression of the ferroptosis-related protein GPX4 and inhibited iron deposition in mice with MI/R injury. Ginsenoside Rg3 also activated the Nrf2 signaling pathway. Ginsenoside Rg3 attenuated myocardial ischemia/reperfusion-induced ferroptosis via the Nrf2 signaling pathway. Notably, ginsenoside Rg3 regulated the keap1/Nrf2 signaling pathway to attenuate OGD/R-induced ferroptosis in H9C2 cells. Taken together, ginsenoside Rg3 attenuated myocardial ischemia/reperfusion-induced ferroptosis via the keap1/Nrf2/GPX4 signaling pathway.</p><p><strong>Conclusions: </strong>Our findings demonstrated that ginsenoside Rg3 ameliorate MI/R-induced ferroptosis via the keap1/Nrf2/GPX4 signaling pathway.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11209975/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141455251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BMC Complementary Medicine and Therapies
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1